ITPD940054A1
(it)
|
1994-03-23 |
1995-09-23 |
Fidia Advanced Biopolymers Srl |
Polisaccaridi solfatati
|
WO1996024362A1
(fr)
*
|
1995-02-07 |
1996-08-15 |
Shiseido Company, Ltd. |
Agents anti-inflammatoires
|
IT1282219B1
(it)
*
|
1995-12-20 |
1998-03-16 |
Fidia Advanced Biopolymers Srl |
Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
|
GB2317182B
(en)
*
|
1996-09-11 |
2000-11-01 |
Johnson & Johnson Medical |
Sulfated polysaccharides and uses thereof in medical treatment
|
ES2189166T3
(es)
*
|
1997-04-04 |
2003-07-01 |
Fidia Advanced Biopolymers Srl |
Compuestos del acido hialuronico n-sulfatado, sus derivados y proceso para su preparacion.
|
IT1291452B1
(it)
|
1997-04-14 |
1999-01-11 |
Fidia Advanced Biopolymers Srl |
Rivestimento a base di acido ialuronico e suoi derivati per la protezione di parti elettroniche da agenti esterni
|
WO1998053829A1
(en)
*
|
1997-05-27 |
1998-12-03 |
Akzo Nobel N.V. |
Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
|
IT1293484B1
(it)
*
|
1997-06-11 |
1999-03-01 |
Fidia Advanced Biopolymers Srl |
Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
|
IT1294797B1
(it)
*
|
1997-07-28 |
1999-04-15 |
Fidia Advanced Biopolymers Srl |
Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
|
US5945457A
(en)
*
|
1997-10-01 |
1999-08-31 |
A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science |
Process for preparing biologically compatible polymers and their use in medical devices
|
ITPD980037A1
(it)
*
|
1998-02-25 |
1999-08-25 |
Fidia Advanced Biopolymers Srl |
Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti
|
DE19813234A1
(de)
*
|
1998-03-26 |
1999-09-30 |
Knoell Hans Forschung Ev |
Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren
|
US6872819B1
(en)
|
1998-05-27 |
2005-03-29 |
Fidia Advanced Biopolymers S.R.L. |
Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
|
ITPD980149A1
(it)
|
1998-06-17 |
1999-12-17 |
Fidia Advanced Biopolymers Srl |
Protesi tridimensionali comprendenti derivati dell'acido ialuronico per riparare o ricostruire i tessuti danneggiati e processo per la
|
US6388060B1
(en)
|
1998-11-06 |
2002-05-14 |
Vascular Therapeutics Inc. |
Process for the sulfation of uronic acid-containing polysaccharides
|
NZ512676A
(en)
|
1999-01-13 |
2003-01-31 |
Meditech Res Ltd |
A composition and method for the enhancement of the efficacy of drugs
|
IT1306644B1
(it)
|
1999-04-08 |
2001-10-02 |
Fidia Advanced Biopolymers Srl |
Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
|
AU2599501A
(en)
*
|
1999-12-29 |
2001-07-09 |
Advanced Cardiovascular Systems Inc. |
Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
|
EP1292314A2
(de)
*
|
2000-05-23 |
2003-03-19 |
The Trustees of Columbia University in the City of New York |
Methode zur behandlung von krankheiten der atemwege durch einsatz von glycosaminoglycane
|
US9066919B2
(en)
*
|
2000-07-14 |
2015-06-30 |
Alchemia Oncology Pty Limited |
Hyaluronan as a chemo-sensitizer in the treatment of cancer
|
AUPQ879500A0
(en)
*
|
2000-07-14 |
2000-08-10 |
Meditech Research Limited |
Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
|
DE10053053A1
(de)
*
|
2000-10-19 |
2002-05-16 |
Knoell Hans Forschung Ev |
Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
|
US7618652B2
(en)
|
2001-03-23 |
2009-11-17 |
Hepmarin As |
Glycosaminoglycan anticoagulants derived from fish
|
ITPD20010108A1
(it)
*
|
2001-05-08 |
2002-11-08 |
Fidia Advanced Biopolymers Srl |
Biomateriali polimerici elettricamente conduttori, loro processo di preparazione ed impiego nel settore biomedico sanitario.
|
ITTS20010013A1
(it)
*
|
2001-06-04 |
2002-12-04 |
Ct Ricerche Poly Tec H A R L S |
Nuovi derivati di ialuronano.
|
US8101196B2
(en)
*
|
2001-06-26 |
2012-01-24 |
Biointeractions, Ltd. |
Polysaccharide biomaterials and methods of use thereof
|
ITMI20011633A1
(it)
|
2001-07-27 |
2003-01-27 |
San Raffaele Centro Fond |
Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
|
CN1578677A
(zh)
*
|
2001-08-27 |
2005-02-09 |
美迪泰克研究有限公司 |
改良的治疗方案
|
US6806259B2
(en)
*
|
2001-12-21 |
2004-10-19 |
Soft Gel Technologies, Inc. |
Hyaluronic Acid in soft gel form
|
US7923431B2
(en)
*
|
2001-12-21 |
2011-04-12 |
Ferrosan Medical Devices A/S |
Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
|
ITPD20020003A1
(it)
*
|
2002-01-11 |
2003-07-11 |
Fidia Advanced Biopolymers Srl |
Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.
|
ITPD20020064A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Fidia Advanced Biopolymers Srl |
Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
|
BR0310087A
(pt)
*
|
2002-05-17 |
2005-08-16 |
Wyeth Corp |
Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
|
EP1539193A4
(de)
*
|
2002-07-03 |
2010-05-05 |
Pericor Science Inc |
Zusammensetzungen von hyaluronsäure und verwendungsverfahren
|
NZ538266A
(en)
|
2002-08-16 |
2007-05-31 |
Denki Kagaku Kogyo Kk |
Separate type medical material
|
ITPD20020271A1
(it)
|
2002-10-18 |
2004-04-19 |
Fidia Farmaceutici |
Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
|
AU2003284634A1
(en)
|
2002-11-21 |
2004-06-15 |
Chugai Seiyaku Kabushiki Kaisha |
Sustained release drug carrier
|
CA2509914A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Ferrosan A/S |
Gelatine-based materials as swabs
|
US7238677B2
(en)
*
|
2003-03-28 |
2007-07-03 |
Kimberly-Clark Worldwide, Inc. |
Prevention of urogenital infections
|
JP2006513791A
(ja)
*
|
2003-04-04 |
2006-04-27 |
ベイコ テック リミテッド |
血管用ステント
|
JP4212970B2
(ja)
*
|
2003-06-30 |
2009-01-21 |
株式会社キーエンス |
安全リレーシステム
|
US20050095219A1
(en)
*
|
2003-10-29 |
2005-05-05 |
Shu-Ping Yang |
Compositions for promoting vaginal cell proliferation and maturation
|
DE10352137A1
(de)
*
|
2003-11-04 |
2005-06-16 |
Beschorner, Katharina, Dr. |
Verwendung sulfatierter Hyaluronsäure
|
DE10360425A1
(de)
*
|
2003-12-19 |
2005-07-28 |
Ursapharm Arzneimittel Gmbh & Co. Kg |
Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
|
WO2005072700A2
(en)
*
|
2004-01-30 |
2005-08-11 |
Ferrosan A/S |
Haemostatic sprays and compositions
|
US20050186269A1
(en)
*
|
2004-02-25 |
2005-08-25 |
Udell Ronald G. |
Stabilized feverfew formulations
|
CN101001649B
(zh)
*
|
2004-07-09 |
2011-08-31 |
弗罗桑医疗设备公司 |
包括透明质酸的止血组合物及其制备方法
|
JP4949241B2
(ja)
*
|
2004-07-12 |
2012-06-06 |
イスト・テクノロジーズ・インコーポレイテッド |
組織マトリックスシステム
|
US8512730B2
(en)
*
|
2004-07-12 |
2013-08-20 |
Isto Technologies, Inc. |
Methods of tissue repair and compositions therefor
|
ITPD20040245A1
(it)
*
|
2004-10-08 |
2005-01-08 |
Fidia Advanced Biopolymers Srl |
Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
|
DE102005004643B4
(de)
*
|
2005-01-28 |
2010-04-08 |
Innovent E.V. Technologieentwicklung |
Antivirale Kombinationen sowie ihre Verwendung
|
ITPD20050206A1
(it)
*
|
2005-07-07 |
2007-01-08 |
Fidia Advanced Biopolymers Srl |
Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione
|
CN103784960A
(zh)
|
2005-07-27 |
2014-05-14 |
阿尔卡米亚肿瘤学股份有限公司 |
使用乙酰透明质酸的治疗方案
|
ITPD20050242A1
(it)
|
2005-08-03 |
2007-02-04 |
Fidia Farmaceutici |
Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
|
US8623354B2
(en)
|
2005-09-07 |
2014-01-07 |
Alchemia Oncology Pty Limited |
Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
|
CA2631520A1
(en)
*
|
2005-12-07 |
2007-06-14 |
Isto Technologies, Inc. |
Cartilage repair methods
|
ITPD20060219A1
(it)
*
|
2006-05-31 |
2007-12-01 |
Fidia Farmaceutici |
Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
|
WO2008090583A1
(en)
*
|
2007-01-22 |
2008-07-31 |
Universita' Degli Studi Di Siena |
Phosphated derivatives of polysaccharides and uses thereof
|
US20080268039A1
(en)
*
|
2007-03-06 |
2008-10-30 |
Soft Gel Technologies, Inc. |
Loquat compositions
|
JP5088864B2
(ja)
*
|
2007-03-16 |
2012-12-05 |
オリンパス株式会社 |
生体組織補填材とその製造方法
|
US8609634B2
(en)
|
2007-05-16 |
2013-12-17 |
Mcneil-Ppc, Inc. |
Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
|
US9579341B2
(en)
|
2007-05-16 |
2017-02-28 |
Johnson & Johnson Consumer Inc. |
Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
|
ITMI20071267A1
(it)
|
2007-06-22 |
2008-12-23 |
Fidia Farmaceutici |
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
|
ITMI20071724A1
(it)
|
2007-09-05 |
2009-03-06 |
Fidia Farmaceutici |
Formulazioni topiche antivirali in forma di gel bioadesivo
|
WO2009046449A1
(en)
*
|
2007-10-05 |
2009-04-09 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Recombinant bacterium capable of eliciting an immune response against enteric pathogens
|
EP2209814B1
(de)
|
2007-11-13 |
2017-01-25 |
Bio-Technology General (Israel) Ltd. |
Verfahren zur sterilisation durch filtration in verdünnter lösung für viskoelastische biopolymere
|
TWI465567B
(zh)
*
|
2007-12-07 |
2014-12-21 |
Univ Nat Cheng Kung |
A method of regulating cell growth
|
CA2716872C
(en)
|
2008-02-29 |
2015-02-10 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
US20090286289A1
(en)
*
|
2008-03-10 |
2009-11-19 |
Pang Danny Z |
Production of Hyaluronate Unsaturated Disaccharides and its Application
|
BRPI0909849A2
(pt)
|
2008-04-04 |
2015-10-06 |
Univ Utah Res Found |
éteres semi-sintéticos de glicosaminoglicosanos e métodos para fazê-los e usá-los
|
US8343942B2
(en)
*
|
2008-04-04 |
2013-01-01 |
University Of Utah Research Foundation |
Methods for treating interstitial cystitis
|
US8426196B2
(en)
*
|
2008-06-05 |
2013-04-23 |
Lynn L. H. Huang |
Method for regulating proliferation of cells
|
EP3184552B1
(de)
|
2008-09-02 |
2020-08-12 |
Tautona Group LP |
Stränge aus hyaluronsäure, verfahren zur herstellung davon und verwendungen davon
|
US10577568B2
(en)
*
|
2008-11-13 |
2020-03-03 |
Novozymes A/S |
Detergent composition
|
WO2010086696A1
(en)
|
2009-01-28 |
2010-08-05 |
Therapol |
Low-molecular-weight sulphated polysaccharides as candidates for anti-angiogenic therapy
|
IT1393945B1
(it)
|
2009-04-21 |
2012-05-17 |
Fidia Farmaceutici |
Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche
|
IT1397247B1
(it)
|
2009-05-14 |
2013-01-04 |
Fidia Farmaceutici |
Nuovi agenti regolatori dell'attivita' citochinica
|
IT1397246B1
(it)
*
|
2009-05-14 |
2013-01-04 |
Fidia Farmaceutici |
Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
|
US8546353B2
(en)
*
|
2010-05-06 |
2013-10-01 |
Glykos Finland Oy |
Compounds and combinations
|
US20130209531A1
(en)
*
|
2010-06-08 |
2013-08-15 |
University Of Utah Research Foundation |
Applications of partially and fully sulfated hyaluronan
|
ES2385239B1
(es)
|
2010-09-30 |
2013-06-19 |
Proteos Biotech S.L.U. |
Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
|
JP6062917B2
(ja)
|
2011-03-23 |
2017-01-18 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション |
泌尿器科の炎症の治療及び予防の方法
|
RU2657955C2
(ru)
|
2012-03-06 |
2018-06-18 |
Ферросан Медикал Дивайсиз А/С |
Контейнер под давлением, содержащий гемостатическую пасту
|
ITPD20120098A1
(it)
|
2012-03-30 |
2013-10-01 |
Fidia Farmaceutici |
"nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
|
ITMI20120664A1
(it)
|
2012-04-20 |
2013-10-21 |
Anika Therapeutics Srl |
Biomateriali a base di gellano per l'uso come filler in chirurgia
|
BR112014030962A2
(pt)
|
2012-06-12 |
2017-06-27 |
Ferrosan Medical Devices As |
métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
|
US10245306B2
(en)
|
2012-11-16 |
2019-04-02 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
CA2932532C
(en)
|
2012-12-04 |
2021-06-22 |
Phosphorex, Inc. |
Microparticles and nanoparticles having negative surface charges
|
US10000582B2
(en)
*
|
2013-04-02 |
2018-06-19 |
The Regents Of The University Of California |
Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
|
RU2700162C2
(ru)
|
2013-06-21 |
2019-09-13 |
Ферросан Медикал Дивайсиз А/С |
Расширенная под вакуумом сухая композиция и шприц для ее сохранения
|
BR112016006512B1
(pt)
|
2013-11-22 |
2021-11-23 |
Somahlution, Llc |
Kits, métodos para preparar solução de conservação de órgãos e tecidos e métodos para conservação de órgãos e tecidos
|
EP3470094B1
(de)
|
2013-12-11 |
2020-07-22 |
Ferrosan Medical Devices A/S |
Trockenzusammensetzung mit extrusionsverstärker
|
EP3154550B1
(de)
|
2014-06-15 |
2021-08-04 |
Yeda Research and Development Co. Ltd. |
Oberflächenbehandlung durch wasserlösliche polymere und lipide/liposome
|
US10179191B2
(en)
|
2014-10-09 |
2019-01-15 |
Isto Technologies Ii, Llc |
Flexible tissue matrix and methods for joint repair
|
CA2960309A1
(en)
|
2014-10-13 |
2016-04-21 |
Ferrosan Medical Devices A/S |
Dry composition for use in haemostasis and wound healing
|
CN107206165B
(zh)
|
2014-12-24 |
2020-10-23 |
弗罗桑医疗设备公司 |
用于保持并混合第一和第二物质的注射器
|
WO2016159296A1
(ja)
*
|
2015-03-31 |
2016-10-06 |
生化学工業株式会社 |
グリコサミノグリカンの硫酸化方法
|
AU2016290433B2
(en)
|
2015-07-03 |
2018-05-24 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
ITUB20155623A1
(it)
*
|
2015-11-16 |
2017-05-16 |
Fidia Farm Spa |
Processo migliorato per la produzione di HA solfatato di elevata purezza
|
KR20190009303A
(ko)
|
2016-04-27 |
2019-01-28 |
아니카 테라퓨틱스, 인코포레이티드 |
건 퇴행의 치료에 사용하기 위한 조성물
|
US11337994B2
(en)
|
2016-09-15 |
2022-05-24 |
University Of Utah Research Foundation |
In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
|
AU2018298224A1
(en)
|
2017-07-07 |
2020-01-30 |
Symic Ip, Llc |
Synthetic bioconjugates
|
US11896642B2
(en)
|
2017-07-07 |
2024-02-13 |
Symic Holdings, Inc. |
Bioconjugates with chemically modified backbones
|
US11129862B2
(en)
|
2017-08-30 |
2021-09-28 |
Johnson & Johnson Consumer Inc. |
Ophthalmic compositions
|
WO2020144372A1
(en)
|
2019-01-10 |
2020-07-16 |
The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin |
Composite viscoelastic hydrogel, and uses thereof for sealing a channel in tissue
|
EP4368217A2
(de)
|
2018-01-10 |
2024-05-15 |
The Provost, Fellows, Scholars and other Members of Board of Trinity College Dublin |
System und verfahren zum abdichten eines kanals in gewebe
|
WO2019163948A1
(ja)
*
|
2018-02-23 |
2019-08-29 |
学校法人創価大学 |
細胞培養用基材及び培養方法
|
IT201900006250A1
(it)
|
2019-04-23 |
2020-10-23 |
Fidia Farm Spa |
Medicazione per il trattamento della cute lesa
|
WO2019215572A1
(en)
*
|
2018-05-08 |
2019-11-14 |
Fidia Farmaceutici S.P.A. |
Wound dressing for treatment of damaged skin
|
WO2019215274A1
(en)
|
2018-05-09 |
2019-11-14 |
Ferrosan Medical Devices A/S |
Method for preparing a haemostatic composition
|
WO2020016820A1
(en)
|
2018-07-18 |
2020-01-23 |
Bio-Technology General (Israel) Ltd. |
Process of, and arrangement for, sterile filtering a non-newtonian liquid and formulation of a liquid obtainable thereby
|
IT201900003887A1
(it)
|
2019-03-18 |
2020-09-18 |
Fidia Farm Spa |
Sistemi di stabilizzazione e di rilascio controllato di farmaci instabili alla sterilizzazione
|
EP3976123A1
(de)
|
2019-05-31 |
2022-04-06 |
University College Dublin |
Hyaluronsäurebasiertes hybridhydrogel
|
KR102277244B1
(ko)
*
|
2019-09-03 |
2021-07-13 |
인제대학교 산학협력단 |
생체 영상화 및 광열치료용 탄소양자점-폴리피롤 나노 복합체 및 이의 제조방법
|
FR3118037B1
(fr)
*
|
2020-12-17 |
2023-10-06 |
Commissariat Energie Atomique |
Acide hyaluronique modifié et sa mise en œuvre comme dopant de polymères de type PEDOT et/ou PProDOT
|
IT202000032243A1
(it)
|
2020-12-23 |
2022-06-23 |
Fidia Farm Spa |
Nuovi agenti antivirali
|
IT202100012737A1
(it)
|
2021-05-18 |
2022-11-18 |
Jointherapeutics S R L |
Miscele di polisaccaridi e poliamminosaccaridi con proprietà reologiche migliorate
|
IT202100013787A1
(it)
|
2021-05-27 |
2022-11-27 |
Farmigea Spa |
Composizione per l’uso nel trattamento di affezioni oculari, quali sindrome dell’occhio secco, specialmente post-chirurgico oftalmico / a composition for use in the treatment of ocular affections, such as dry eye disease, especially after eye surgery
|
CN113754795B
(zh)
*
|
2021-10-19 |
2023-03-10 |
澳门大学 |
磺酸化透明质酸类化合物、其制备方法及其应用
|
IT202100032111A1
(it)
|
2021-12-22 |
2023-06-22 |
Fidia Farm Spa |
Nuovi sostituti biocompatibili dell’umor vitreo
|
IT202200004613A1
(it)
|
2022-03-10 |
2023-09-10 |
Cmed Aesthetics S R L |
“procedimento di preparazione di prodotti sterili”
|